Abstract
Idiosyncratic drug-induced liver injury (DILI) is an important differential diagnosis in patients with abnormal liver tests.1 The presentation is acute in the vast majority of cases, and the diagnosis is challenging. DILI is the most common cause of acute liver failure in the US2 and Europe,3 but in India, viral hepatitis is the most common cause, followed by liver injury due to antituberculosis (anti-TB) therapy.4 During the last two decades, interest in the study of DILI has increased considerably.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
